GTR 86708710

Bids Are Invited For Formation Of A Price Registry To Hire A Company Specialized In The Relevant Field For The Installment Purchase Of Medicines Intended For Specialized Pharmacy, For Patient Care, In Accordance With The Municipalitys Medical Protocol.

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
86708710
Tendering Authority
Subscribe to view
Tender No
0000121/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Formation Of A Price Registry To Hire A Company Specialized In The Relevant Field For The Installment Purchase Of Medicines Intended For Specialized Pharmacy, For Patient Care, In Accordance With The Municipalitys Medical Protocol.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
24-10-2024 Closed
Work Detail
Valproic Acid 50 Mg/Ml Br 0308732, Amitriptyline Hydrochloride 10 Mg Br 434111, Amitriptyline Hydrochloride Associated With Chlordiazepoxide 12.5Mg + 5Mg Br 0276336, Amlodipine Besylate Associated With Benazepril Hydrochloride 5 Mg + 20 Mg Br 394917, Amlodipine Besylate Associated With Perindopril Arginine 10 Mg + 14 Mg, Br 476553, 03/10/2024, Bamifylline Hydrochloride 600 Mg Br 272027, Beclomethasone Dipropionate Assoc. With Glycopyrronium Bromide And Formoterol 100 + 12.5 + 6 Mcg/Dose Br 0470130, Beclomethasone Dipropionate Associated With Formoterol Fumarate 100 Mcg + 6 Mcg/Dose Br 407441, Brexpiprazole 3 Mg Br473336, Brimonidine Tartrate 2 Mg/Ml Eye Drops Br 268352, Brinzolamide 10Mg+Timolol Maleate 5 Mg/Ml Br 395807, Bromazepam 3 Mg Br 0271773, Bromazepam 6 Mg Br 271774, Budesonide 6 Ml Br266705, Buprenorphine 10 Mg, Buspirone Hydrochloride 10 Mg Br 272573, Candesartan Com Hydrochlorothiazide16mg + 12 Br280873, Carmelose Sodium 5 Mg/Ml Br0305428, Cyproterone Acetate 50 Mg Br268077, Clozapine 100 Mg Br272431, Codeine 30 Mg Br 272782, Collagenase 0.6Ui/G Br 268958, Cholecalciferol 1000 Iu Br 0434125, Cholecalciferol 15,000 Iu Br 0601402, Cholecalciferol 2,000 Iu Br 0442729, Cholecalciferol 3,000 Iu Br 0601404, Cholecalciferol 5,000 Iu Br 0430434, Cholecalciferol 50,000 Iu Br 431098, Cholecalciferol 7,000 Iu Br 431097, Dapagliflozin Associated With Saxagliptin 10 Mg + 5 Mg Br485637 , Haloperidol Decanoate 50 Mg/Ml Ampoule 1 Ml, Denosumab 60 Mg/Ml Br 0421223, Desloratadine 0.5 Mg/Ml Br 0337468, Desloratadine 5 Mg Br 0287529, Dexlansoprazole 30 Mg Br461415, Dexlansoprazole 60 Mg Br450073, Dextran 70 Associated With Hypromellose 0.1% + 0. 3% Br 0396741, Diltiazem Hydrochloride 120Mg Br267572 , Donepezil, Composition:Associated With Memantine, Concentration:10 Mg + 15 Mg, Br479847, Edoxaban 30 Mg Br 464129, Edoxaban, Composition:Tosylate, Concentration:60 Mg, Br459805, Empagliflozin, Composition:Associated With Linagliptin, Concentration:10 Mg + 5 Mg, Br479975, Concentration:10 Mg, Br437078, Eszopiclone, Concentration:3 Mg, Br466368, Ezetimibe, Composition:Associated With Rosuvastatin, Concentration:10Mg + 10 Mg Cod Br 0485127, Composition:Associated With Simvastatin, Concentration:10Mg + 40 Mg, Br285689, Flurazepam, Dosage:30 Mg Cod Br 0273011, Galantamine, Composition: Hydrobromide Salt, Concentration:24 Mg Cod Br 0315734, Hydroxychloroquine Sulfate 400 Mg Br 268119, Imiquimod, Concentration:50 Mg/G, Pharmaceutical Form: C Row ? Sachet 0.25 Gr, Human Anti Rho(D) Immunoglobulin 300 Mcg Injectable 2 Ml Br 266827, Indacaterol Maleate, Concentration:300 Mcg, Pharmaceutical Form:Capsule Inhalant Powder, Additional Feature:With Inhaler, Br404448, Bacterial Isate, Composition:H . Influenzae, D. Pneumoniae, K.Pneumoniae, Other Components:K. Ozaenae, S. Aureus, S. Pyogenes, S. Viridans, Additional Components: And Moraxella Catarrhalis (Neisseria), Concentration: 7 Mg, Br433149, Leflunomide, Dosage: 20 Mg, Br268114, Levodopa Associated With Benserazide, Dosage: 100Mg + 25Mg , Linagliptin, Concentration:5 Mg Cod Br 0407214, Lisdexamfetamine Dimesylate, Concentration:70 Mg Cod Br 0407326, Lurasidone, Concentration:20 Mg, Br452624, Concentration:80 Mg, Br452625, Mesalazine, Concentration:1 G, Pharmaceutical Form:Rectal Use , Br292240, Concentration:500 Mg, Br352414, Metformin Hydrochloride, Associated With Dapaglifozin 1000 Mg + 5Mg 441621, Composition: Associated With Dapaglifozin, Concentration:1000 Mg + 10 Mg, Pharmaceutical Form: Prolonged Action, Br452438, A Hydrochloride 50 Mg Br 273266 , Ornithine, Composition: Aspartate Salt, Concentration: 600 M
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
4c90a7af-6c43-4e9d-8d1b-cd4704f41b61.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders